| Grove City Vision Center | |
|
3959 Hoover Rd, Grove City, OH 43123-2839 | |
| (614) 875-8373 | |
| (614) 875-0974 |
| Full Name | Grove City Vision Center |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 3959 Hoover Rd, Grove City, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316386501 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 5472 (Ohio) | Primary |
| Provider Name | Timothy D Fries |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1538168943 PECOS PAC ID: 6507828415 Enrollment ID: I20041102001234 |
News Archive
A combination regimen of venetoclax and azacitidine was safe and improved overall survival (OS) over azacitidine alone in certain patients with acute myeloid leukemia (AML), according to the Phase III VIALE-A trial led by The University of Texas MD Anderson Cancer Center.
Brainlab announced the availability of ExacTrac® Infrared Monitoring, an add-on device to existing treatment machines for monitoring patient positioning during radiation therapy treatments, at the American Association of Physicists in Medicine (AAPM) Annual Meeting last week.
Avita Medical Ltd., the regenerative medicine company, is pleased to announce that it has successfully completed the transfer and acquisition of intellectual property currently licensed through the McComb Foundation of Western Australia.
The risk for pertussis infection in children who receive the combined diphtheria, tetanus, and acellular pertussis vaccine increases by an average of 42% per year after the last dose, a US study shows.
A recently completed study by scientists at the Oregon Research Institute (ORI) in Eugene confirmed earlier findings from a pilot study that walking on a cobblestone mat surface resulted in significant reductions in blood pressure and improvements in balance and physical performance among adults 60 and over.
› Verified 4 days ago
| Provider Name | Eric Eugene Neader |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1821175373 PECOS PAC ID: 3779507371 Enrollment ID: I20060123000643 |
News Archive
A combination regimen of venetoclax and azacitidine was safe and improved overall survival (OS) over azacitidine alone in certain patients with acute myeloid leukemia (AML), according to the Phase III VIALE-A trial led by The University of Texas MD Anderson Cancer Center.
Brainlab announced the availability of ExacTrac® Infrared Monitoring, an add-on device to existing treatment machines for monitoring patient positioning during radiation therapy treatments, at the American Association of Physicists in Medicine (AAPM) Annual Meeting last week.
Avita Medical Ltd., the regenerative medicine company, is pleased to announce that it has successfully completed the transfer and acquisition of intellectual property currently licensed through the McComb Foundation of Western Australia.
The risk for pertussis infection in children who receive the combined diphtheria, tetanus, and acellular pertussis vaccine increases by an average of 42% per year after the last dose, a US study shows.
A recently completed study by scientists at the Oregon Research Institute (ORI) in Eugene confirmed earlier findings from a pilot study that walking on a cobblestone mat surface resulted in significant reductions in blood pressure and improvements in balance and physical performance among adults 60 and over.
› Verified 4 days ago
| Provider Name | Justin M Miller |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1396173217 PECOS PAC ID: 8123345402 Enrollment ID: I20150325001974 |
News Archive
A combination regimen of venetoclax and azacitidine was safe and improved overall survival (OS) over azacitidine alone in certain patients with acute myeloid leukemia (AML), according to the Phase III VIALE-A trial led by The University of Texas MD Anderson Cancer Center.
Brainlab announced the availability of ExacTrac® Infrared Monitoring, an add-on device to existing treatment machines for monitoring patient positioning during radiation therapy treatments, at the American Association of Physicists in Medicine (AAPM) Annual Meeting last week.
Avita Medical Ltd., the regenerative medicine company, is pleased to announce that it has successfully completed the transfer and acquisition of intellectual property currently licensed through the McComb Foundation of Western Australia.
The risk for pertussis infection in children who receive the combined diphtheria, tetanus, and acellular pertussis vaccine increases by an average of 42% per year after the last dose, a US study shows.
A recently completed study by scientists at the Oregon Research Institute (ORI) in Eugene confirmed earlier findings from a pilot study that walking on a cobblestone mat surface resulted in significant reductions in blood pressure and improvements in balance and physical performance among adults 60 and over.
› Verified 4 days ago
| Provider Name | Angela L Greenslait |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1891862272 PECOS PAC ID: 0345337689 Enrollment ID: I20151013002251 |
News Archive
A combination regimen of venetoclax and azacitidine was safe and improved overall survival (OS) over azacitidine alone in certain patients with acute myeloid leukemia (AML), according to the Phase III VIALE-A trial led by The University of Texas MD Anderson Cancer Center.
Brainlab announced the availability of ExacTrac® Infrared Monitoring, an add-on device to existing treatment machines for monitoring patient positioning during radiation therapy treatments, at the American Association of Physicists in Medicine (AAPM) Annual Meeting last week.
Avita Medical Ltd., the regenerative medicine company, is pleased to announce that it has successfully completed the transfer and acquisition of intellectual property currently licensed through the McComb Foundation of Western Australia.
The risk for pertussis infection in children who receive the combined diphtheria, tetanus, and acellular pertussis vaccine increases by an average of 42% per year after the last dose, a US study shows.
A recently completed study by scientists at the Oregon Research Institute (ORI) in Eugene confirmed earlier findings from a pilot study that walking on a cobblestone mat surface resulted in significant reductions in blood pressure and improvements in balance and physical performance among adults 60 and over.
› Verified 4 days ago
| Provider Name | Kaitlynn Taylor Bock |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1235544909 PECOS PAC ID: 4880996966 Enrollment ID: I20160106001616 |
News Archive
A combination regimen of venetoclax and azacitidine was safe and improved overall survival (OS) over azacitidine alone in certain patients with acute myeloid leukemia (AML), according to the Phase III VIALE-A trial led by The University of Texas MD Anderson Cancer Center.
Brainlab announced the availability of ExacTrac® Infrared Monitoring, an add-on device to existing treatment machines for monitoring patient positioning during radiation therapy treatments, at the American Association of Physicists in Medicine (AAPM) Annual Meeting last week.
Avita Medical Ltd., the regenerative medicine company, is pleased to announce that it has successfully completed the transfer and acquisition of intellectual property currently licensed through the McComb Foundation of Western Australia.
The risk for pertussis infection in children who receive the combined diphtheria, tetanus, and acellular pertussis vaccine increases by an average of 42% per year after the last dose, a US study shows.
A recently completed study by scientists at the Oregon Research Institute (ORI) in Eugene confirmed earlier findings from a pilot study that walking on a cobblestone mat surface resulted in significant reductions in blood pressure and improvements in balance and physical performance among adults 60 and over.
› Verified 4 days ago
| Provider Name | Kayli Nicole Dennis |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1457917023 PECOS PAC ID: 3476989997 Enrollment ID: I20200131001883 |
News Archive
A combination regimen of venetoclax and azacitidine was safe and improved overall survival (OS) over azacitidine alone in certain patients with acute myeloid leukemia (AML), according to the Phase III VIALE-A trial led by The University of Texas MD Anderson Cancer Center.
Brainlab announced the availability of ExacTrac® Infrared Monitoring, an add-on device to existing treatment machines for monitoring patient positioning during radiation therapy treatments, at the American Association of Physicists in Medicine (AAPM) Annual Meeting last week.
Avita Medical Ltd., the regenerative medicine company, is pleased to announce that it has successfully completed the transfer and acquisition of intellectual property currently licensed through the McComb Foundation of Western Australia.
The risk for pertussis infection in children who receive the combined diphtheria, tetanus, and acellular pertussis vaccine increases by an average of 42% per year after the last dose, a US study shows.
A recently completed study by scientists at the Oregon Research Institute (ORI) in Eugene confirmed earlier findings from a pilot study that walking on a cobblestone mat surface resulted in significant reductions in blood pressure and improvements in balance and physical performance among adults 60 and over.
› Verified 4 days ago
| Provider Name | Eriq Hall |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1790420685 PECOS PAC ID: 7810377322 Enrollment ID: I20220630000265 |
News Archive
A combination regimen of venetoclax and azacitidine was safe and improved overall survival (OS) over azacitidine alone in certain patients with acute myeloid leukemia (AML), according to the Phase III VIALE-A trial led by The University of Texas MD Anderson Cancer Center.
Brainlab announced the availability of ExacTrac® Infrared Monitoring, an add-on device to existing treatment machines for monitoring patient positioning during radiation therapy treatments, at the American Association of Physicists in Medicine (AAPM) Annual Meeting last week.
Avita Medical Ltd., the regenerative medicine company, is pleased to announce that it has successfully completed the transfer and acquisition of intellectual property currently licensed through the McComb Foundation of Western Australia.
The risk for pertussis infection in children who receive the combined diphtheria, tetanus, and acellular pertussis vaccine increases by an average of 42% per year after the last dose, a US study shows.
A recently completed study by scientists at the Oregon Research Institute (ORI) in Eugene confirmed earlier findings from a pilot study that walking on a cobblestone mat surface resulted in significant reductions in blood pressure and improvements in balance and physical performance among adults 60 and over.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Grove City Vision Center 3959 Hoover Rd, Grove City, OH 43123-2839 Ph: (614) 875-8373 | Grove City Vision Center 3959 Hoover Rd, Grove City, OH 43123-2839 Ph: (614) 875-8373 |
News Archive
A combination regimen of venetoclax and azacitidine was safe and improved overall survival (OS) over azacitidine alone in certain patients with acute myeloid leukemia (AML), according to the Phase III VIALE-A trial led by The University of Texas MD Anderson Cancer Center.
Brainlab announced the availability of ExacTrac® Infrared Monitoring, an add-on device to existing treatment machines for monitoring patient positioning during radiation therapy treatments, at the American Association of Physicists in Medicine (AAPM) Annual Meeting last week.
Avita Medical Ltd., the regenerative medicine company, is pleased to announce that it has successfully completed the transfer and acquisition of intellectual property currently licensed through the McComb Foundation of Western Australia.
The risk for pertussis infection in children who receive the combined diphtheria, tetanus, and acellular pertussis vaccine increases by an average of 42% per year after the last dose, a US study shows.
A recently completed study by scientists at the Oregon Research Institute (ORI) in Eugene confirmed earlier findings from a pilot study that walking on a cobblestone mat surface resulted in significant reductions in blood pressure and improvements in balance and physical performance among adults 60 and over.
› Verified 4 days ago
Dr. Kristin S Middlesworth, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1770 Stringtown Rd, Grove City, OH 43123 Phone: 614-801-9193 Fax: 614-801-9288 | |
Dr. Marc S Hartig, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4140 Hoover Rd, Grove City, OH 43123 Phone: 614-801-2020 Fax: 614-801-0001 | |
Dr. Lawrence A Gill, OD Optometrist Medicare: Medicare Enrolled Practice Location: 3814 Broadway, Grove City, OH 43123 Phone: 614-871-2080 Fax: 614-871-1301 | |
Chris A. Smiley, O.d. And Associates, Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3814 Broadway, Grove City, OH 43123 Phone: 614-871-2080 | |
Dr. Lacey Jacobs, Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4172 Buckeye Pkwy, Grove City, OH 43123 Phone: 614-782-9048 | |
Dr. Joseph P. Leisring I, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3814 Broadway, Grove City, OH 43123 Phone: 614-871-2080 Fax: 614-871-1301 | |
John W Zahara, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3959 Hoover Rd, Grove City, OH 43123 Phone: 614-875-8373 Fax: 614-875-0974 |